| Literature DB >> 34786853 |
Nanqi Mao1, Fangyuan Xue1, Wanyu Cai1, Jiahong Li1.
Abstract
Patients who have undergone carotid revascularization surgery have a high risk of postoperative cognitive decline, and home-based care is the major form of postoperative management. Here, we aimed to compare the nurse-led home-based telephone support (NLHBTS) and home visits as additional postoperative care for patients who have undergone carotid revascularization surgery. The study recruited 172 patients, and 131 patients were randomly assigned to receive combined telephone support and home visits (intervention group) or home visits alone (control group) during the study period of 12 weeks. At baseline, 1 month, and 3 months, cognitive function was assessed using the Trail Making Test, Processing Speed Index, Boston Naming Test, Working Memory Index, Controlled Oral Word Association Test, and Hopkins Verbal Test. Sixty-five patients in the intervention group and 66 in the control group completed the 1-month treatment, and 49 in the intervention group and 48 in the control group completed the 3-month treatment. The intervention group showed significant improvement in four of the six cognitive tests after the 3-month treatment, whereas the control group only showed significant improvement in the Controlled Oral Word Association Test. Compared to the control group, significantly higher scores were achieved by the intervention group at 3 months in the Trail Making Tests (113 ± 23 vs. 128 ± 18, p = 0.001), Processing Speed Index (115 ± 15 vs. 108 ± 14, p = 0.020), Controlled Oral Word Association Test (51 ± 11 vs. 45 ± 9, p = 0.004), and Hopkins Verbal Learning Test (9.0 ± 1.6 vs. 8.3 ± 1.8, p = 0.046). NLHBTS, in combination with home visits, could facilitate the improvement of cognitive function in patients with carotid artery stenosis after surgery.Entities:
Mesh:
Year: 2021 PMID: 34786853 PMCID: PMC8932695 DOI: 10.1111/cts.13195
Source DB: PubMed Journal: Clin Transl Sci ISSN: 1752-8054 Impact factor: 4.689
Schedule, contents, and goals of each intervention for patients with CAS of both the intervention and control groups
| Time | Contents | Goals |
|---|---|---|
| Week 0 |
Face‐to‐face counseling with the patients. Explain the training method and teach patients how to receive home follow‐up monitoring services delivered using telephone support. |
Establish a trusting relationship. Record information, including medication control, education, and general risks of patients. Introduction to the program and aims of the study. |
| Week 2 |
Identify the patient’s thought patterns and negative feelings, and give the patient proper guidance. Encouragement to pursue goals and information given if needed. |
Create a harmonious way of life to transfer the patient’s focus from illness. Help patients to build positive thoughts and self‐perception. |
| Week 4 |
Ask patients’ thoughts and feelings about illness. Collect information about cognitive functions. |
Relieve the patient’s tension and psychological pressure. |
| Week 6 |
Encourage patients to express their feelings about stressful experience. Guide patients on accepting themselves, and developing a positive self‐concept. Guide patients on finding positive coping methods. |
Correction of perceptions regarding body image and the self‐concept. Improve problem‐solving strategies, reinforcing physical, emotional, and spiritual coping strategies. |
| Week 8 |
Understand difficulties regarding family relationships and finding positive solutions. Encourage patients to express their thoughts and feelings. |
Relieve the patient’s tension and psychological pressure. |
| Week 10 |
Ask their thoughts and feelings, and give advice to release pressure. Share experiences with other patients. Help patients to develop their own strategies. |
Avoid the accumulation of anxiety, tension, and other negative emotions. |
| Week 12 |
Encourage patients to reflect on their gains and losses from the treatment. Emphasize on what to be cautious of at a later stage. Close the program. |
Collect information. Statistical analysis. |
FIGURE 1Flow diagram of the study
Demographic and clinical characteristics in the two treatment groups
| Intervention group ( | Control group ( |
| |
|---|---|---|---|
| Demographic characteristics | |||
| Age, years, mean (SD) | 73 (8.9) | 68 (7.6) | 0.475 |
| Gender, | 0.428 | ||
| Male | 31(63.27) | 34 (70.83) | |
| Female | 18 (36.73) | 14 (29.17) | |
| Educational level, | 0.618 | ||
| Middle or high school | 32 (65.31) | 29 (60.42) | |
| ≥College | 17 (34.69) | 19 (39.58) | |
| General risks, | |||
| History of smoking | 21 (42.86) | 23 (47.92) | 0.617 |
| Hypertension | 41 (83.67) | 39 (81.25) | 0.754 |
| Hyperlipidemia | 38 (77.55) | 40 (83.33) | 0.473 |
| Atrial fibrillation | 2 (4.08) | 2 (4.17) | 0.983 |
| Diabetes | 10 (20.41) | 12 (25.00) | 0.589 |
| Obesity | 9 (18.37) | 10 (20.83) | 0.760 |
| PVD | 14 (28.57) | 12 (25.00) | 0.691 |
| COPD | 5 (10.20) | 5 (10.42) | 0.973 |
| Contralateral occlusion | 1 (2.04) | 4 (8.33) | 0.161 |
Data were shown as n (%) or mean (SD).
Abbreviations: COPD, chronic obstructive pulmonary disease; PVD, peripheral vascular disease.
Change in cognitive functioning between intervention group and control group
| Research group |
| Effect size | |||
|---|---|---|---|---|---|
| Intervention group ( | Control group ( | ||||
| Trail Making Test A and B | Baseline (T0) | 120 (18) | 125 (22) | 0.224 | 0.23 |
| 1 month (T1) | 116 (21) | 122 (26) | 0.215 | 0.23 | |
| 3 months (T2) | 113 (23) | 128 (18) | 0.001 | 0.83 | |
|
| 0.314 | 0.543 | |||
|
| 0.097 | 0.467 | |||
| Processing Speed Index | Baseline (T0) | 106 (13) | 107 (8) | 0.649 | 0.13 |
| 1 month (T1) | 113 (16) | 106 (18) | 0.050 | 0.39 | |
| 3 months (T2) | 115 (15) | 108 (14) | 0.020 | 0.5 | |
|
| 0.020 | 0.726 | |||
|
| 0.002 | 0.669 | |||
| Boston Naming Test | Baseline (T0) | 52 (8) | 53 (9) | 0.565 | 0.11 |
| 1 month (T1) | 53 (7) | 54 (6) | 0.452 | 0.17 | |
| 3 months (T2) | 55 (8) | 56 (10) | 0.588 | 0.1 | |
|
| 0.512 | 0.524 | |||
|
| 0.067 | 0.126 | |||
| Working Memory Index | Baseline (T0) | 101 (12) | 104 (15) | 0.280 | 0.2 |
| 1 month (T1) | 106 (13) | 105 (12) | 0.694 | 0.08 | |
| 3 months (T2) | 108 (11) | 105 (10) | 0.163 | 0.3 | |
|
| 0.050 | 0.719 | |||
|
| 0.003 | 0.702 | |||
| Controlled Oral Word Association Test | Baseline (T0) | 40 (8) | 41 (9) | 0.565 | 0.11 |
| 1 month (T1) | 45 (10) | 43 (11) | 0.352 | 0.18 | |
| 3 months (T2) | 51 (11) | 45 (9) | 0.004 | 0.67 | |
|
| 0.008 | 0.332 | |||
|
| <0.001 | 0.030 | |||
| Hopkins Verbal Learning Test | Baseline (T0) | 7.9 (1.8) | 8.1 (1.7) | 0.575 | 0.12 |
| 1 month (T1) | 8.3 (2.0) | 8.2 (1.9) | 0.801 | 0.05 | |
| 3 months (T2) | 9.0 (1.6) | 8.3 (1.8) | 0.046 | 0.39 | |
|
| 0.301 | 0.786 | |||
|
| 0.002 | 0.577 | |||
Data were shown as mean (SD).
Abbreviations: COPD, chronic obstructive pulmonary disease; PVD, peripheral vascular disease.
Indicates statistically significant p values.